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Abstract
Background: Zinc (Zn) is an essential trace element. However, Zn bioavailability from commonly consumed
plants may be reduced due to phytic acid. Zn supplementation has been used to treat diarrheal disease in children,
and in the U.S. swine industry at pharmacological levels to promote growth and fecal consistency, but underlying
mechanisms explaining these beneficial effects remain unknown. Moreover, adding supplemental phytase
improves Zn bioavailability. Thus, we hypothesized that benefits of pharmacological Zn supplementation result
from changes in gene expression that could be further affected by supplemental phytase. The goal of this study
was to investigate the effects of feeding newly weaned pigs dietary Zn (150, 1,000, or 2,000 mg Zn/kg) as Zn oxide
with or without phytase [500 phytase units (FTU)/kg] for 14 d on hepatic gene expression. Liver RNA from pigs
fed 150, 1,000, or 2,000 mg Zn/kg, or 1,000 mg Zn/kg with phytase (n = 4 per treatment) was reverse transcribed
and examined using the differential display reverse transcription polymerase chain reaction technique. Liver RNA
from pigs fed 150 or 2,000 mg Zn/kg (n = 4 per treatment) was also evaluated using a 70-mer oligonucleotide
microarray.
Results:  Expressed sequence tags for 61 putatively differentially expressed transcripts were cloned and
sequenced. In addition, interrogation of a 13,297 element oligonucleotide microarray revealed 650 annotated
transcripts (FDR ≤ 0.05) affected by pharmacological Zn supplementation. Seven transcripts exhibiting differential
expression in pigs fed pharmacological Zn with sequence similarities to genes encoding GLO1, PRDX4, ACY1,
ORM1, CPB2, GSTM4, and HSP70.2 were selected for confirmation. Relative hepatic GLO1 (P < 0.0007), PRDX4 (P
< 0.009) and ACY1 (P < 0.01) mRNA abundances were confirmed to be greater in pigs fed 1,000 (n = 8) and 2,000
(n = 8) mg Zn/kg than in pigs fed 150 (n = 7) mg Zn/kg. Relative hepatic HSP70.2 (P < 0.002) mRNA abundance
was confirmed to be lower in pigs fed 2,000 mg Zn/kg than in pigs fed 150 or 1,000 mg Zn/kg.
Conclusion: Results suggest that feeding pharmacological Zn (1,000 or 2,000 mg Zn/kg) affects genes involved
in reducing oxidative stress and in amino acid metabolism, which are essential for cell detoxification and proper
cell function.
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Background
Differential gene expression is responsible for morpho-
logical and phenotypical differences among animals,
since the transcriptome is dynamic [1]. Studies on how
micronutrients affect gene expression will help to clarify
the role of trace elements in health and metabolism and
their connection to biochemical events [2]. The trace min-
eral zinc (Zn) is involved in gene expression in numerous
ways including DNA replication, RNA transcription,
through the activity of transcription factors, DNA and
RNA polymerases, signal transduction, oxidative stress
and playing a role in programmed cell death [3]. It was
recently estimated that almost 3,000 different proteins
encoded by the human genome bind zinc [4]. An example
of such proteins is metallothionein (MT), which exerts a
protective effect against stress by acting as an antioxidant,
and as a Zn storage and transfer protein [5]. Furthermore,
the transcriptional regulation of the MT gene by dietary
Zn has been demonstrated in rats [6].
In developing countries Zn deficiency is caused by inges-
tion of high cereal protein diets rich in phytic acid, an
organic form of phosphorus (P) [7]. In addition, common
animal feedstuffs contain 60–80% of the total P in the
phytic acid molecule, which make Zn unavailable for
absorption [8]. Rats fed diets containing 3,000 mg Zn/kg
and phytic acid absorb less and excrete more Zn [9]. This
may be explained by the formation of mineral-phytic acid
complexes, plus the negligible amount of endogenous
phytase production in mammals. Therefore, the tendency
to excrete phytic acid bound minerals in the feces is
increased, and mineral absorption is decreased. Phytase
supplementation studies in pigs demonstrate increased
plasma Zn concentration [10,11], greater Zn retention
[12], and improved bone mineralization [13], while add-
ing phytase to human diets also results in increased iron
absorption [14]. Thus, phytase supplementation provides
a potential solution to improve Zn availability.
In humans, Zn supplementation has been shown to
reduce the morbidity of diarrhea [15], respiratory disease
[16], and nematode infection [17]. Moreover, high Zn
supplementation to weaned pigs has been successful in
increasing growth and decreasing diarrhea [18], while
feeding pharmacological Zn (3,000 mg Zn/kg) to weaned
pigs improves fecal consistency and also intestinal mor-
phology by increasing villous height and reducing crypt
depths of the duodenum and jejunum [19]. However,
molecular analyses of the effects of pharmacological Zn to
explain the favorable symptoms observed when Zn is sup-
plemented in high quantities have not been undertaken.
We previously reported that feeding the recommended
amounts of phytase (500 FTU/kg) and pharmacological
Zn (1,000 – 2,000 mg/kg) to newly weaned pigs increased
MT mRNA abundance and protein concentrations in the
liver, kidney and intestinal mucosa [11]. Thus, additional
genes are also likely to be affected by this dietary interven-
tion and serve as the basis for the improved health effects
obtained with pharmacological Zn supplementation.
Therefore, the objective of this experiment was to deter-
mine the identity of genes that are differentially expressed
in the liver of pigs fed diets with or without pharmacolog-
ical Zn, and to determine if phytase supplementation fur-
ther affected gene expression by using differential display
reverse transcription polymerase chain reaction (DDRT-
PCR) and oligonucleotide microarray technologies. In
this paper we report 61 amplicons identified by DDRT-
PCR and 650 annotated genes (FDR ≤ 0.05) identified by
microarray analysis with putative differential gene expres-
sion, of which 5 transcripts with roles in oxidative stress
reduction and amino acid metabolism were confirmed to
have differential expression in pigs fed pharmacological
Zn diets.
Results
Identification of expressed sequences displayed by DDRT-
PCR
A total of 66 putatively differentially expressed amplicons
were cloned and sequenced. High quality nucleotide
sequence data was obtained for 61 of these expressed
sequence tags (ESTs) and all were submitted to the Gen-
Bank database [GenBank:CB826605 – CB826610, Gen-
Bank:CF106636 – CF106687, GenBank:DW177047 –
DW177050]. A search of the EMBL/GenBank and TIGR
databases revealed that 29 of the ESTs (48%) had signifi-
cant similarities to genes with known identities, 7 were
similar to mitochondrial DNA (11%), and the 25 remain-
ing sequences (41%) had unknown identities (Table 1).
Identified genes were similar to genes involved in signal
transduction (48%), nucleic acid metabolism (17%), oxi-
dative stress response (11%), protein and amino acid
metabolism (10%), blood coagulation (7%), and struc-
tural roles (7%). Various mRNA abundance patterns were
observed among the dietary treatment groups (Table 1)
and 5 genes were selected for subsequent confirmation
analyses.
Identification of differentially expressed genes by 
oligonucleotide microarray analysis
To further monitor gene expression changes due to phar-
macological Zn supplementation, we conducted a tran-
scriptional profiling analysis using a commercially
available pig 70-mer oligonucleotide set spotted on glass
slide microarrays. The hepatic transcript abundance pat-
terns from animals fed 150 mg Zn/kg (Zn150) compared
to animals fed 2,000 mg Zn/kg (Zn2000) revealed 683
annotated genes that were significantly altered at a false
discovery rate (FDR) adjusted P ≤ 0.05, plus several hun-
dred additional un-annotated oligonucleotides. Several ofB
M
C
 
G
e
n
o
m
i
c
s
 
2
0
0
8
,
 
9
:
4
2
1
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
1
6
4
/
9
/
4
2
1
P
a
g
e
 
3
 
o
f
 
1
4
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 1: List of differentially expressed products and sequence identity information from differential display reverse transcription PCR.
EST ID (Length – bp) Sequence IDa Species/Accession No.b Porcine TC numberc Pattern of transcript abun-
danced
Signal Transduction Genes
CF106654 (152) Activator heat shock 90 kDa protein ATPase 
homologue 1 (AHSA1)
B. taurus/NM_001034666.1 TC243227 3 = 4 > 2 > 1
CF106663 (151) Activator heat shock 90 kDa protein ATPase 
homologue 1 (AHSA1)
B. taurus/NM_001034666.1 TC243227 3 = 4 > 2 > 1
CF106649 (240) Golgi autoantigen, golgin subfamily b, 
macrogolgin (with transmembrane signal) 1, 
(GOLGB1)
H. sapiens/NM_004487.3 TC269106 1 > 2 = 3 = 4
CF106669 (441) Interferon induced with helicase C domain 1 
(IFIH1)
H. sapiens/NM_022168.2 TC281891 3 > 4 > 2 > 1
CB826605 (152)e N-myc downstream regulated gene 1 
(NDRG1)
B. taurus/NM_001035009.1 TC257462 1 > 4
CB826606 (130)e Orosomucoid 1 (ORM1) S. scrofa/PIGA1AG TC273225 1 > 4
CF106636 (484) Orosomucoid 1 (ORM1) S. scrofa/PIGA1AG TC273225 4 > 3 > 2 = 1
CF106686 (546) Orosomucoid 1 (ORM1) S. scrofa/PIGA1AG TC273225 3 = 4 > 2 = 1
CF106640 (240) Progesterone receptor membrane 
component 1 (PGRMC1)
S. scrofa/NM_213911.1 TC238451 4 = 3 > 2 > 1
CF106680 (272) Progestin and adipoQ receptor family 
member VII (PAQR7)
S. scrofa/NM_213739.1 TC238374 3 > 4 > 2 = 1
CF106679 (354) Ras, member oncogene family (RAB2A) C. familiaris/NM_001003318.1 TC241036 4 = 3 > 2 > 1
CF106667 (620) Ribosomal protein L17 (RPL17) B. taurus/NM_001034459.1 TC264931 4 > 3 > 2 > 1
CF106653 (407) Ribosomal protein SA (RPSA) S. scrofa/AM050292.2 TC269871 3 > 4 = 2 > 1
DW177048 (174) Tight junction protein 1 (zona occludens 1, 
TJP1)
C. familiaris/NM_001003140.1 TC281469 2 = 3 > 1
CF106648 (228) Tyrosine 3-monooxygenase/Tryptophan 5-
monooxygenase activation protein, beta 
polypeptide (YWHAB)
H. sapiens/NM_139323.2 TC251407 3 = 4 = 2 > 1
CF106651 (310) Wilms' tumour associating protein (WTAP) H. sapiens/NM_004906.3 TC267553 4 = 3 > 2 > 1
Nucleic Acid Metabolism Genes
CF106652 (492) Basic Transcription Factor 3 (BTF3) H. sapiens/NM_001207.4 TC241093 4 = 2 > 3 > 1
CF106681 (396) DNA Polymerase Beta (POLB) B. taurus/NM_001034764.1 TC252856 4 = 1 > 3 > 2
CF106666 (623) Heterogeneous nuclear ribonucleoprotein K 
(HNRPK)
H. sapiens/NM_002140.2 TC260259 4 = 3 = 2 > 1
CF106673 (385) La ribonucleoprotein family, member 4 
(LARP4)
H. sapiens/NM_199190.1 TC244218 3 > 2 > 1 > 4
Oxidative Stress Genes
CF106641 (364) Flavin containing monooxygenase 3 (FMO3) B. taurus/NM_174057.2 TC251612 1 > 2 = 3 = 4
CF106665 (479) Glyoxalase I (GLO1) B. taurus/NM_001083496.1 TC254694 4 > 3 > 2 > 1
CF106659 (349) Peroxiredoxin (PRDX4) B. taurus/NM_174433.2 TC239253 4 = 3 > 2 > 1
Blood Cogulation Genes
CF106687 (278) Carboxypeptidase B2 (CPB2) H. sapiens/NM_001872.3 TC240093 3 = 4 > 2 = 1
CF106639 (374) Coagulation Factor IX (F9) H. sapiens/NM_000133.2 TC286008 4 > 2 > 3 = 1
CF106662 (269) Histidine Rich Glycoprotein (HRG) B. taurus/NM_173919.2 TC251128 3 > 4 > 2 = 1B
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Protein and Amino Acid Metabolism Genes
CF106650 (196) N-Aminoacylase I (ACY-1) S. scrofa/NM_213896.1 TC269425 4 = 3 = 2 > 1
CF106684 (295) Polyubiquitin (UBB) B. taurus/NM_174133.2 TC260685 3 = 4 > 2 = 1
Structural Genes
CF106657 (384) Integrin alpha-6 (ITGA6) H. sapiens/NM_000210.2 TC285515 1 > 2 = 3 = 4
Mitochondrial DNA Genes
CF106643 (300) Mitochondrial DNA S. scrofa/AB292606.1 TC259884 1 > 3 > 2 = 4
CF106645 (177) Mitochondrial DNA S. scrofa/AB292606.1 TC259884 1 > 2 > 3 = 4
CF106671 (297) Mitochondrial DNA S. scrofa/AB292606.1 TC259884 4 = 3 > 2 > 1
CF106646 (156) Mitochondrial DNA S. scrofa/AB292606.1 SINGLETON 3 > 4 > 2 = 1
CF106664 (336) Mitochondrial DNA S. scrofa/AB292606.1 TC270954 1 > 2 > 3 = 4
CF106675 (334) Mitochondrial DNA S. scrofa/AB292606.1 TC270954 3 > 4 = 2 = 1
CF106647 (207) Mitochondrial DNA S. scrofa/AB292606.1 TC239708 3 > 4 = 2 = 1
Unknown Identity Genes
CB826607 (112)e No significant match SINGLETON 1 > 4
CB826608 (288)e No significant match TC292722 1 > 4
CB826609 (250)e No significant match SINGLETON 1 > 4
CB826610 (147)e No significant match TC263361 1 > 4
CF106637 (262) No significant match TC269532 4 = 3 > 2 > 1
CF106638 (366) No significant match SINGLETON 4 = 2 > 2 > 1
CF106642 (557) No significant match SINGLETON 1 > 2 = 4 > 3
CF106644 (312) No significant match SINGLETON 1 > 2 = 3 = 4
CF106655 (211) No significant match SINGLETON 3 = 4 > 2 > 1
CF106656 (222) No significant match SINGLETON 1 = 3 > 2 > 4
CF106658 (294) No significant match TC288854 4 = 2 > 3 = 1
CF106660 (209) No significant match SINGLETON 1 > 4 = 3 > 2
CF106661 (228) No significant match SINGLETON 1 = 2 > 3 > 4
CF106668 (223) No significant match SINGLETON 1 > 2 = 3 = 4
CF106670 (225) No significant match TC264413 1 = 3 > 4 > 2
CF106672 (372) No significant match TC275435 3 > 2 > 1 > 4
CF106674 (536) No significant match SINGLETON 3 > 1 = 2 = 4
CF106676 (225) No significant match TC264413 3 = 1 > 4 > 2
CF106678 (434) No significant match TC284960 3 > 4 = 2 = 1
CF106682 (317) No significant match TC264213 3 > 4 > 2 = 1
CF106683 (364) No significant match TC256701 3 > 4 > 2 = 1
CF106685 (227) No significant match SINGLETON 1 = 4 > 2 < 3
DW177047 (247) No significant match TC241849 3 > 1 = 2
DW177049 (158) No significant match SINGLETON 2 > 1 = 3
DW177050 (133) No significant match TC248509 1 = 2 > 3
aAmplicons were compared to GenBank database using the BLASTN software v. 2.2.17 August 26, 2007.
bSpecies, GenBank accession number for most significant match.
cAmplicons were compared to TIGR Sus scrofa gene index v.12.0 updated June 20, 2006 using the BLAST software v. 2.0. Singleton denotes sequences unassigned to a TC.
dPattern of transcript abundance observed on DDRT-PCR gels. 1 = Zn150; 2 = Zn1000; 3 = Zn1000P; 4 = Zn2000. Pattern observed in the display gel from highest (>) to lowest or comparable 
(=) abundance.
eAmplicons detected in Exp. 1.
Table 1: List of differentially expressed products and sequence identity information from differential display reverse transcription PCR. (Continued)BMC Genomics 2008, 9:421 http://www.biomedcentral.com/1471-2164/9/421
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these probes represent multiple spots of the same oligo-
nucleotide. Taking this into account, a total of 650 unique
genes were identified as differentially expressed at FDR ≤
0.05 in the microarray analysis [see Additional file 1].
These genes have been categorized according to functional
groups, and the file contains the oligonucleotide ID, fold
change, raw and adjusted P values, and annotation for
each gene.
Confirmation of differential expression as affected by 
dietary treatment
In the present study, we focused on genes differentially
expressed due to pharmacological Zn supplementation,
and further evaluated if their expression was affected by
phytase supplementation. A total of 7 genes were selected
from the display gels and microarray hybridization results
that exhibited different relative mRNA abundance in the
liver of pigs fed pharmacological Zn diets without phytase
(Zn1000, Zn2000) versus pigs fed Zn150. In addition to these
7 genes, an oligonucleotide for MT on the microarray was
observed to exhibit a 3.8-fold higher hepatic mRNA abun-
dance in pigs fed Zn2000 than in pigs fed Zn150, a result
which we have already confirmed in our previous study
where we reported hepatic MT  mRNA abundance and
protein concentration to be significantly higher in pigs fed
pharmacological Zn diets than in pigs fed an adequate Zn
diet [11]. To confirm differential gene expression, a com-
bination of relative real time RT-PCR and northern blot
analyses were utilized with all 7 animals from Exp. 1 (fed
Zn150 or Zn2000without phytase), and all 23 animals of
Exp.2, which were fed the six dietary treatments.
Three oxidative stress response genes involved in the
reduction of peroxides [peroxiredoxin 4 (PRDX4)], detoxi-
fication of glycating agents [glyoxalase I (GLO1)], and
transfer of glutathione [glutathione transferase M4
(GSTM4)], exhibited differential expression. Northern
blot analysis of PRDX4  revealed a single transcript of
~0.95 kb (Figure 1), which agrees with the size reported
for human PRDX4 [20]. Real time reverse transcription
PCR (RT-PCR) was used to examine mRNA abundance of
PRDX4. Relative abundance of PRDX4 mRNA (Figure 2A)
in liver of pigs fed pharmacological Zn diets was 2 fold
higher in pigs fed Zn1000, and 4 fold higher in pigs fed
Zn2000 when compared to pigs fed Zn150 (P < 0.009). This
result was supported by the subsequent microarray analy-
sis which revealed significantly higher hybridization to a
PRDX4 oligonucleotide present on the array by the Zn2000
samples than by the Zn150 samples (data not shown).
PCR amplification efficiency plots revealed that GAPDH
was not a suitable normalizing gene for GLO1, therefore
northern blot hybridization was performed for confirma-
tion of GLO1. A single transcript (~1.9 kb) was observed
(Figure 1), which was in accordance with the size of
human GLO1 [21]. Relative GLO1 mRNA abundance was
greater (P < 0.0007) in pigs fed pharmacological Zn diets
(Zn1000 and Zn2000) when compared to pigs fed adequate
Northern blots of GLO1, ACY1 and PRDX4 Figure 1
Northern blots of GLO1, ACY1 and PRDX4. Northern blot analysis of liver GLO1, ACY1 and PRDX4 mRNA of pigs fed 150, 
1,000 or 2,000 mg Zn/kg (with or without phytase) for 14 d post-weaning (Exp.2). Liver total RNA (12 μg) isolated from each 
pig was analyzed using the cDNA clones derived from differential display gels as probes. Also shown is 18S rRNA hybridization 
to assess equivalence of RNA loading.BMC Genomics 2008, 9:421 http://www.biomedcentral.com/1471-2164/9/421
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Gene expression confirmation of DDRT-PCR and microarray transcripts Figure 2
Gene expression confirmation of DDRT-PCR and microarray transcripts. Relative mRNA abundance of selected 
transcripts was confirmed using real time RT-PCR or nothern blot analyses in pigs fed 150, 1,000 or 2,000 mg Zn/kg for 14 d 
post-weaning. A) PRDX4 mRNA Abundance. Relative real time RT-PCR was performed and fold changes relative to 
GAPDH and a common Zn150 reference sample are presented. Values are means ± SEM, n = 8, (except Zn150, n = 7). A signifi-
cant zinc effect was detected for relative PRDX4 mRNA abundance, P < 0.009. No Zn by phytase interaction, or phytase effect 
were detected. B) GLO1 mRNA Abundance. Northern blot analysis was performed and values are mean optical density 
readings ± SEM, n = 8 (except Zn150, n = 7). A significant zinc effect was detected for relative hepatic GLO1 mRNA abundance, 
P < 0.0007. No Zn by phytase interaction, or phytase effect were detected. C) ACY1 mRNA Abundance. Northern blot 
analysis was performed and values are mean optical density readings ± SEM, n = 8 (except Zn150, n = 7). A significant zinc effect 
was detected for relative hepatic ACY1 mRNA abundance, P < 0.01. No Zn by phytase interaction, or phytase effect were 
detected. D) HSP70.2 mRNA Abundance. Relative real time RT-PCR was performed and fold changes relative to Zn2000 
using 18S as normalizing gene are presented. Values are means ± SEM, n = 7, (except Zn2000, n = 8). A significant zinc effect was 
detected for relative HSP70.2 mRNA abundance, P < 0.002. No Zn by phytase interaction, or phytase effect were detected.
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Zn (Figure 2B). Supplemental phytase did not affect the
mRNA abundance of either PRDX4 or GLO1.
Microarray analysis had indicated GSTM4 mRNA abun-
dance to be higher in pigs fed Zn2000 than pigs fed Zn150.
Real time RT-PCR results for GSTM4 supported a trend for
Zn2000 pigs to have higher GSTM4  mRNA abundance,
although it did not reach statistical significance due to
large animal variability. There was a trend for significance
(P < 0.09) towards an interaction between Zn and phytase
supplementation for relative GSTM4 mRNA abundance.
GSTM4  mRNA abundance tended to increase when
phytase was supplemented to the diets of pigs fed ade-
quate (Zn150P) or the first level of pharmacological Zn
(Zn1000P). However, when phytase was supplemented
with the higher level of pharmacological Zn (Zn2000P) no
further increase in expression was observed.
N-aminoacylase I (ACY1) and heat shock protein 70.2
(HSP70.2)  are genes involved in amino acid and heat
shock metabolism that also displayed differential expres-
sion. Northern blot analysis revealed the presence of a sin-
gle  ACY1  transcript (~1.3 kb, Figure 1), which is in
accordance with the size reported for pig ACY1 [22]. Rela-
tive ACY1 mRNA abundance was increased (P < 0.01) in
pigs fed pharmacological Zn (Zn1000 and Zn2000), and no
phytase effect was observed (Figure 2C). Relative abun-
dance of HSP70.2 mRNA in liver of pigs fed Zn150 and
Zn1000 diets was comparable and higher than in pigs fed
Zn2000 (Figure 2D). Supplemental phytase did not affect
the mRNA abundance of HSP70.2.
Based on the differential display gels, an acute phase
response gene, orosomucoid 1 (ORM1), and a gene in the
plasma carboxypeptidase family, carboxypeptidase B2
(CPB2), also exhibited increased mRNA abundance in
pigs fed pharmacological Zn diets. However, these genes
were not confirmed to be differentially expressed in pigs
fed any of the dietary treatments using relative real time
RT-PCR due to large animal variability (data not shown).
Discussion
Differential display reverse transcription PCR is a tech-
nique that allows the simultaneous comparison of multi-
ple treatments for the identification of differentially
regulated mRNAs, and the generation of ESTs that can be
compared with DNA sequences available in current data-
bases to identify genes, including genes in non-conven-
tional biological models such as the pig [23,24]. The
disadvantage of DDRT-PCR vs. microarray approaches is
clearly that it is a much more time consuming technique
to perform. However, DDRT-PCR does have some advan-
tages. Gene discovery with DDRT-PCR does not require
prior knowledge of gene or EST sequences as is needed for
construction of microarrays [25]. In the present study, sev-
eral genes selected for confirmation from the DDRT-PCR
study were not present on the microarray used for subse-
quent analyses despite the relatively large number of oli-
gonucleotides on the microarray (over 13,000). In
addition, DDRT-PCR allows direct comparisons to be
made between more than two samples at a time and it
may be more sensitive for detection of relatively low
abundance transcripts. For this study, DDRT-PCR and oli-
gonucleotide microarray technologies were used to reveal
differentially expressed genes in the liver of pigs fed phar-
macological Zn diets and to determine if expression was
further affected when supplemental phytase was added to
the diets. In total we found 61 ESTs with putative differen-
tial expression using DDRT-PCR among the various treat-
ment groups and identified 650 differentially expressed
(FDR ≤ 0.05) annotated genes with the microarray. Seven
genes were selected for confirmation. This study provides
evidence of a differential hepatic transcriptional profile in
pigs due to consumption of diets containing basal or
pharmacological concentrations of Zn.
The  PRDX4  gene encodes for a ubiquitous cytosolic
enzyme [EC 1.11.1.15], which reduces hydrogen peroxide
via redox-active cysteine residues. In addition to hydrogen
peroxides, Jin and collaborators [20] reported that perox-
iredoxins can also regulate peroxide-mediated signaling
cascades, and their overexpression reduces hydrogen per-
oxides in response to tumor necrosis factor α (TNF-α).
Overexpression of PRDX4 in mice suppresses B-cell
nuclear factor of kappa light polypeptide gene enhancer
(Nf-κB) activation through regulation of B-cell inhibitor
of kappa light polypeptide gene enhancer (I-κB) phos-
phorylation [20]. Gallagher and Phelan reported that
inhibition of Nf-κB leads to an increase in PRDX6 tran-
scription in mouse hepatocytes [26]. Similarly, MT has
also been implicated in inhibiting TNF-induced activation
of Nf-κB DNA binding, by inhibition of I-κB degradation
and subsequent NF-κB suppression [27]. An in vitro study
demonstrated that Zn pretreatment increased the availa-
bility of intracellular Zn ions and abrogated LPS-induced
oxidative stress and I-κB/NF-κB signaling cascade in liver
Kupffer cells [28]. Kim et al. [29] suggest that MT modu-
lates intracellular signaling molecules such as transcrip-
tion factors (Nf-κB) by sequestering intracellular Zn,
which is required for its DNA binding activity. Peroxire-
doxins are considered redox regulators of signal transduc-
tion [20], acting like a switch to control intracellular
pathways. Perhaps the increase in intracellular Zn causes
an alteration in cell signaling [30], and PRDX4 upregula-
tion occurs as a result. In addition, the suppressive effect
of PRDX4 on Nf-κB may be one of the many mechanisms
of how pharmacological Zn, as ZnO enhances health in
the newly weaned pig. For example, studies in Caco-2 cells
exposed to enterotoxigenic E. coli demonstrate that Zn as
ZnO protects these cells by inhibiting bacterial adhesionBMC Genomics 2008, 9:421 http://www.biomedcentral.com/1471-2164/9/421
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and internalization into cells, thus modulating subse-
quent cytokine expression that might occur in response to
pathogenic exposure [31].
Glyoxalase 1 [EC 4.4.1.5] is a cytosolic ubiquitous Zn
metalloenzyme that catalyzes the glutathione dependent
conversion of glycating agents such as methylglyoxal to S-
D-lactoylglutathione via a 1,2-hydrogen transfer [32].
This enzyme works in conjunction with glyoxalase II to
further convert S-D-lactoylglutathione to D-lactate [33].
Methylglyoxal can react with arginine and lysine residues
in proteins, and at high concentrations it inhibits glyco-
lytic enzymes [21], enhances lipid peroxidation, and
binds DNA and RNA causing macromolecular damage
[34]. Genomic analysis of the GLO1 gene revealed the
presence of functional metal response elements (MREs)
located 647 bp downstream of the transcription initiation
site [21]. Another gene containing MREs in its promoter
region is the MT gene [35]. The MREs control transcrip-
tional activation of MT upon exposure to Zn, through the
action of metal transcription factor-1 [36]. Transcriptional
activity of GLO1 in transfected HepG2 cells was elevated
twofold upon exposure to 25 and 75 μM ZnCl2for 48 hr
[21]. We have previously shown that MT mRNA abun-
dance and protein concentration are increased in liver,
kidney and intestinal mucosa of pigs fed pharmacological
Zn [11]. This observation was confirmed for liver MT
mRNA abundance with the microarray analysis in the
present study and similar expression patterns were
observed for PRDX4 and GLO1.
Zinc involvement in oxidative stress is well known. Its
deficiency causes oxidative DNA damage by impairment
of antioxidant defense, and compromises DNA repair
mechanisms [37]. However, the mechanism of how sup-
plemental Zn exerts its antioxidant action is not well
defined. Our current microarray analysis indicated that
mRNA abundances of many oxidative stress molecules are
affected by pharmacological Zn supplementation includ-
ing GSTM4, glutathione peroxidase (GPX), NADPH oxi-
dase (NOX1), heme oxygenase 2 (HMOX2), cytochrome
C oxidase VIIB (COX7B), cytochrome P450 (CYPC27),
and peroxisome proliferator activated receptor gamma-2
(PPARG) [see Additional file 1]. From these, GSTM4 was
selected for confirmation. GSTM4  encodes the fourth
member of the glutathione S-transferase that belongs to
the mu class. The mu class of enzymes function in the
detoxification of electrophilic compounds, including car-
cinogens, therapeutic drugs, environmental toxins and
products of oxidative stress, by conjugation with glutath-
ione [38]. Our results are in agreement with previous
studies where dietary Zn affected the hepatic gene expres-
sion of GST, GPX and  CYP  [39]. In addition to these
genes, it has been suggested that MT induction by Zn in
hepatocytes creates an intracellular pool of thiols and Zn
ions, thus it can act similarly to glutathione which can
then react with the reactive species [40,41]. Moreover, the
ability of Zn to occupy iron and copper binding sites on
lipids, proteins and DNA, may also contribute towards its
antioxidant action [42]. The present study shows that
pharmacological Zn supplementation is associated with
increased mRNA abundance of PRDX4 and GLO1, and a
tendency to increase GSTM4 when combined with dietary
phytase. Interestingly these genes participate in the oxida-
tive stress response through differing mechanisms. Per-
haps the increased intracellular concentrations of Zn exert
an increase in Zn dependent enzymes creating an effective
hepatoprotective role. Our results for hepatic GLO1
expression are in agreement with observations in GLO1
transfected HepG2 cells [21]. It is possible that Zn tran-
scriptionally regulates GLO1 through MRE activation, in a
similar fashion to the MT gene, therefore offering protec-
tion against glycating agents. However, to our knowledge,
we provide the first evidence that dietary pharmacological
Zn increases PRDX4 and GLO1 mRNA abundances. Addi-
tional studies will be undertaken to further clarify the
influence of pharmacological Zn on GSTM4 and related
oxidative stress protein activity in pigs.
Molecular chaperones or stress proteins like heat shock
proteins 70.2 and 90 (Hsp70 and Hsp90), maintain the
correct conformational homeostasis of proteins, helping
newly synthesized proteins to be folded and transported
across membranes and protecting them against a number
of stresses thus playing the role of chaperones [43,44].
The expression of heat shock proteins is under complex
control, but with final common pathways involving the
heat shock factors (HSFs), the function of which is zinc-
dependent [45]. Several heat shock proteins have been
identified including Hsp27, Hsp47, Hsp70 and Hsp90,
and are named according to their molecular weight [46].
In our present study we were able to confirm that pharma-
cological Zn decreases HSP70.2 mRNA abundance in the
liver. Interestingly, in vitro studies [47] which examined
the relationship between protein misfolding, aggregation
and chaperone induction showed that oxidative stress
increased expression of Hsp90. However, mild oxidative
stress did not induce protein denaturation and stress
response. This work also showed that adding Zn induced
chaperone expression and higher Zn concentrations coun-
teracted the heat shock and oxidative stress mediated
induction of chaperones by inhibiting their expression
[47]. These studies support our findings that at higher Zn
concentrations, there is lower abundance of HSP70.2
mRNA.
Three additional genes were selected for confirmation.
ACY1 encodes for a Zn metalloenzyme involved in pep-
tide metabolism, ORM1 encodes for an acute phase reac-
tant protein and CPB2  encodes for a plasmaBMC Genomics 2008, 9:421 http://www.biomedcentral.com/1471-2164/9/421
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carboxypeptidase. ACY1 [EC 3.5.1.14] is a cytosolic
enzyme with highest abundance in pig kidney versus the
liver [22,48]. The biological role of ACY1 is to hydrolyze
neutral and hydrophobic α-N-acyl-L-amino acids gener-
ated during protein degradation [49]. This Zn dependent
enzyme has been identified in mammals primarily in kid-
ney and liver [48], it contains a single Zn atom per subu-
nit, and it is proposed to have catalytic roles [50].
However, Heese et al. [51] suggested that Zn plays a struc-
tural role, because the Zn binding site was too far from the
catalytic site of the enzyme. Results of northern blot anal-
ysis in this study confirm that pharmacological Zn supple-
mentation increases the relative abundance of ACY1
mRNA. No differences were observed in the abundance of
this transcript between animals fed Zn1000 and Zn2000, sug-
gesting that at dietary concentrations greater than 1,000
mg Zn/kg, relative ACY1 abundance reaches a plateau. To
our knowledge, this study provides the first evidence of Zn
effects on the abundance of ACY1 mRNA, suggesting a
role in protein and amino acid metabolism.
Orosomucoid 1 and CPB2 are genes that encode an acute
phase reactant protein known as α-1-acid glycoprotein,
and plasma pro-carboxypeptidase [EC 3.4.17.20], respec-
tively. These plasma proteins are secreted into the blood
after being synthesized in the liver [52,53]. Serum concen-
trations of ORM1 are high in fetal [54] and neonatal pigs,
decreasing markedly to a constant level by 2 wk of age
[55] and declining further by 112 d. In a similar pattern,
liver ORM1 mRNA is relatively abundant in late fetal and
neonatal pigs then declines rapidly after birth [56]. Alpha-
1-acid glycoprotein plasma concentration rises during
inflammation, thus its function is related to modulation
of an inflammatory response primarily caused by inter-
leukin 1, interleukin 6 and glucocorticoids [57]. Sequence
analysis of the murine ORM1 gene revealed the presence
of four MRE sequences in the 5' flanking region, and one
in intron 5 [58]. Furthermore, relative liver ORM1 mRNA
abundance in mice injected i.p. with the heavy metal mer-
cury (0.5 mg Hg/kg) was increased in a time dependent
manner. Zinc was also used to investigate ORM1 mRNA
response upon heavy metal exposure, but its effect on
ORM1 mRNA was not as marked as Hg [59]. The authors
concluded that heavy metals regulate ORM1 at the tran-
scriptional level. Interestingly, we found this gene to be
affected by dietary treatment in both experiments using
different anchor and arbitrary primer combinations,
although the pattern of transcript abundance differed. We
did not confirm a significant effect of dietary Zn on liver
ORM1 mRNA abundance for pigs in either experiment
using relative real time RT-PCR.
Plasma CPB2 [E.C. 3.4.17.20] is a carboxypeptidase that
appears in plasma after clotting of blood [60]. Several
names have been used for this enzyme according to its
general catalytic mechanism, including carboxypeptidase
U (U = unstable), carboxypeptidase R (R = cleaves Arg and
Lys residues in C-termini), plasma carboxypeptidase B (B
= basic) and most recently thrombin-activatable fibrinol-
ysis inhibitor (TAFI) [61]. Eaton et al. [62] showed that
CPB2 becomes inactive upon addition of a Zn chelating
agent, 1,10-phenantroline. The presence of CPB2 has
been demonstrated in the pig, rabbit and mouse, with
activity ranging from 20% (mouse) to 500% (pig) com-
pared to human serum CPB2 [63]. The physiological func-
tion of CPB2 is to inhibit fibrinolysis by removing C-
terminal lysine residues from fibrin and limiting plasmin
formation [64]. Fibrinogen is also secreted during an
inflammatory response, suggesting that overexpression of
CPB2 could be part of a mechanism to decrease inflam-
mation.
Our display gels indicated that pharmacological Zn
increases the mRNA abundance of ORM1 (for Exp. 2 pigs)
and CPB2 in pig liver. However, relative real time PCR
results did not confirm their differential expression. The
inability to confirm the differential display observations
may be due to the low number of pigs examined along
with relatively high variability in transcript abundance
between pigs or the increased sensitivity of the real time
RT-PCR assays.
Conclusion
The EST data obtained and submitted to the GenBank
database as well as the transcriptional profiling from the
microarray study provide sequence and differential gene
expression information for hepatic genes in the pig. In
addition, this study provides important information that
contributes to understanding the benefits of feeding phar-
macological Zn diets to pigs. New mechanisms affected by
dietary Zn were evaluated and can be further considered
in future studies, including the role of Zn in reducing oxi-
dative stress and protein metabolism, both processes that
are essential for cell detoxification and function.
Methods
Animals and diets
Animals and diet composition have been previously
described [11]. A smaller preliminary study was per-
formed to optimize the technique (Exp. 1). For Exp.1 the
dietary treatments fed to pigs for 14 d were: 1) basal Zn
diet containing 150 mg Zn/kg (Zn150), 2) pharmacologi-
cal Zn diet containing 2,000 mg Zn/kg (Zn2000). The die-
tary treatments fed to pigs in Exp. 2 for 14 d were: 1)
adequate Zn diet containing 150 mg Zn/kg (Zn150), 2)
Zn150 plus 500 phytase units (FTU)/kg (Zn150P), 3) phar-
macological Zn diet containing 1,000 mg Zn/kg (Zn1000),
4) Zn1000 plus 500 FTU/kg (Zn1000P), 5) pharmacological
Zn diet containing 2,000 mg Zn/kg (Zn2000), or 6) Zn2000
plus 500 FTU/kg (Zn2000P). Pigs were provided feed andBMC Genomics 2008, 9:421 http://www.biomedcentral.com/1471-2164/9/421
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water ad libitum. This project was approved by the Michi-
gan State University All University Committee on Animal
Use and Care (12/99-159-00).
Sample collection and total RNA isolation
Details about euthanasia, liver sample collection and total
RNA isolation were previously published [11]. Liver sam-
ples were obtained from 3 pigs per treatment for Exp. 1 (n
= 6 total) and from 4 pigs per treatment for Exp. 2 (n = 24
total). RNA quality and integrity were determined by cal-
culating the A260/280 ratio and by agarose gel electrophore-
sis, respectively. Additionally, RNA quality and quantity
were further confirmed with the RNA 6000 Pico LabChip®
kit using an Agilent 2100 Bioanalyzer (Agilent Technolo-
gies, Palo Alto, CA).
Differential display reverse transcription polymerase chain 
reaction (DDRT-PCR)
DDRT-PCR experiments were performed as previously
reported by our laboratory [65] using modifications of
published procedures [23]. Briefly, genomic DNA con-
tamination was minimized by treating 1 μg of total RNA
with 1 U of amplification grade DNAse I (Invitrogen, Life
Technologies, Carlsbad, CA) according to the manufac-
turer's protocol. Individual DNAse treated RNA samples
(200 ng) from animals fed Zn150 and Zn2000 (n = 3 per
treatment in Exp.1) and fed Zn150, Zn1000, Zn1000P and
Zn2000, (n = 4 per treatment in Exp. 2), were reverse tran-
scribed by using anchor primers (Exp. 1 – Anchors #2 and
#7, Exp.2 – Anchor #9) and RT-mix [1× Buffer, 25 μM
dNTPs, 10 mM DTT and 40 U of Superscript II (Invitro-
gen, Life Technologies, Carlsbad, CA)]. Samples were
incubated at 40°C for 5 min, 50°C for 50 min, and 70°C
for 15 min in a Peltier Thermal Cycler (PTC-200, MJ
Research). A final temperature drop to 4°C stopped the
reaction.
Oligonucleotide primers for DDRT-PCR were obtained
from the U.S. Pig Genome Coordination Program http://
www.animalgenome.org/pigs/resources/ddprimer.html,
and those used for these experiments were randomly
selected (Table 2). For Exp. 1, 2 anchor primers were
paired with 2 arbitrary primers on 6 cDNA samples and a
total of 24 PCR amplicons were generated. For Exp. 2, 1
anchor primer paired with 6 arbitrary primers on 16
cDNA samples resulted in a total of 96 PCR amplicons,
thus ~5% of all mRNA species present were screened. PCR
reactions were performed using cDNA (400 ng) in a solu-
tion containing 0.2 μM 3'-anchor primer, 20 μM of each
dNTP, 1.5 mM MgCl2, 1× PCR buffer, 0.2 μM 5' – arbitrary
primer, 2.5 μCi [α-33P] dATP (Perkin Elmer, Life Sciences
Inc., Boston, MA) and 0.5 U Taq DNA Polymerase
(Promega, Madison, WI). PCR cycling parameters were:
95°C for 2 min, four cycles at 92°C for 15 s, 50°C for 30
s, and 72°C for 2 min, followed by an additional 25 cycles
with annealing at 60°C for 30 s and extension at 72°C for
2 min.
Denaturing loading dye (96% formamide, 2%
bromophenol blue and 2% xylene cyanol) was mixed
with each DDRT-PCR sample (8 μl), and samples were
dried on medium heat for 5 min using a speed-vacuum
(Savant Instruments Inc., Farmingdale, NY) followed by a
3 min 95°C denaturing step. The samples were electro-
phoresed on 0.4 mm 5.2% polyacrylamide denaturing
gels. Following a 5–6 hr run at 60 W on a vertical gel box
(Model S2, Invitrogen, Life Technologies/GIBCO BRL
Sequence Systems, Carlsbad, CA), gels were transferred
onto Whatman chromatography paper (Whatman®,
Maidstone, England) and dried at 80°C for 30 min using
a slab dryer (SGD 2000, Savant). Gels were exposed to
Biomax™ film (Eastman Kodak Co., Rochester, NY) over-
night.
Excision and re-amplification of DDRT-PCR products
Radiographs were developed and subsequently carefully
evaluated to detect differences in transcript abundance by
visually comparing bands among the different dietary
treatments. Transcripts were selected that exhibited a con-
sistent band intensity among samples within treatments
and different intensities across treatments. A band inten-
sity scale to describe the pattern of transcript abundance
was created by assigning a representative number to each
dietary treatment (1 = Zn150; 2 = Zn1000; 3 = Zn1000P; 4 =
Zn2000) observed in the display gel from highest (>) to
lowest or comparable (=) abundance (Table 1). Selected
bands were circumscribed from the gels, re-hydrated in
100 μl DEPC-treated water and heated at 50°C for 30
min. Re-amplification reactions included 2 μl of gel band
eluate and the anchor and arbitrary primers used in the
DDRT-PCR step under the same reaction conditions and
cycling parameters described above, excluding the iso-
Table 2: Anchor and arbitrary primersa.
Primer identification number Primer sequence
Anchor # 2 d(T)12 ACb 5'-TTTTTTTTTTTTGC-3'
Anchor # 7 d(T)12 ACb 5'-TTTTTTTTTTTTCG-3'
Anchor # 9 d(T)12 ACc 5'-TTTTTTTTTTTTAC-3'
Arbitrary # 4c 5'-GCTAGCAGAC-3'
Arbitrary # 7c 5'-TGGATTGGTC-3'
Arbitrary # 9c 5'-TAAGCCTAGC-3'
Arbitrary # 13c 5'-GTTGCACCAT-3'
Arbitrary # 14b 5'-TCCATGACTC-3'
Arbitrary # 16d 5'-TCGGTCATAG-3'
Arbitrary # 18b 5'-TGATGCTACC-3'
Arbitrary # 20c 5'-TCGATACAGG-3'
aSource: http://www.animalgenome.org/pigs/resources/ddprimer.html.
bUsed in Exp. 1.
cUsed in Exp. 2.
dUsed in Exp. 1 & 2.BMC Genomics 2008, 9:421 http://www.biomedcentral.com/1471-2164/9/421
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tope. To assess quality of the reactions, 1 and 2 μl of re-
amplified products were electrophoresed with a λ Hind III
marker (Invitrogen, Life Technologies, Carlsbad, CA) in
1% agarose gels stained with ethidium bromide (Sigma-
Aldrich, St. Louis, MO).
Cloning and sequencing of DDRT-PCR products
Products of interest obtained from the DDRT-PCR gels
were cloned into pGEM-T-Easy Vector-System I (Promega,
Madison, WI). Recombinant vectors were transformed
into E. coli DH5α competent cells (Invitrogen, Life Tech-
nologies, Carlsbad, CA). Plasmid DNA was purified with
the QIAprep Spin Miniprep kit (Qiagen, Valencia, Ca) and
digested with EcoR I to confirm the presence of an insert.
Sequencing was performed using SP6 or M13 forward
primers at the Michigan State University Research Tech-
nology Support Facility (MSU RTSF). Putative identifica-
tion of the amplicons was determined using the basic
local alignment search tool (BLASTn) software, with the
non-redundant and EST databases of GenBank and The
Institute for Genomic Research (TIGR) database. Correct
gene name and abbreviation was corroborated using the
Gene Cards® database http://www.genecards.org.
Oligonucleotide microarray analysis
Oligonucleotide microarrays used for this study consisted
of 13,297 70-mer oligos (Pig Array-Ready Oligo Set v. 1.0
and Pig Oligo Extension Set v. 1.0, Qiagen, Inc., Valencia,
CA) each spotted once on a single slide. Slides were
printed at the MSU RTSF. Oligonucleotides spotted in
multiple locations for use as potential controls included
76 Arabidopsis thaliana gene spots, 17 beta tubulin spots,
17 glyceraldehyde-3-phosphate dehydrogenase spots, 85
heat shock protein gene spots, 69 ribosomal protein gene
spots, 112 randomly generated negative control spots and
470 blanks. This microarray has been validated for use in
pig transcriptional profiling studies by Zhao et al. [66].
The microarray was screened with the Zn150 and Zn2000
samples. Zn150 samples were randomly paired with Zn2000
samples using four microarray slides. Two samples from
each treatment were labeled with Cy3 and the other two
were labeled with Cy5.
For each sample, 8 μg of total RNA was reverse transcribed
with an oligo (dT)18 primer using the Superscript™ Indi-
rect cDNA Labeling System (Invitrogen, Carlsbad, CA)
according to the manufacturer's instructions. After first-
strand synthesis and purification, the cDNAs incorporated
amino-modified dUTPs and were labeled with N-hydrox-
ysuccinate (NHS) ester Cy3 or Cy5 dyes (GE Healthcare,
Piscataway, NJ). The labeled cDNAs were purified, com-
bined and concentrated to 10 μl using a microcon spin
column (Millipore, Bedford, MA). The concentrated
probe was combined with 100 μl of Slide Hyb#3 solution
(Ambion, Inc. Austin, TX) and denatured at 70°C for 5
min. Microarray hybridizations took place in sealed
hybridization chambers in a GeneTAC™ Hybridization
Station (Genomic Solutions) for 18 hours using step-
down temperatures ranging from 65°C to 42°C. Follow-
ing hybridization, the slides were washed twice with
medium stringency buffer and once with high stringency
buffer (Genomic Solutions). The slides were rinsed in 2 ×
SSC and deionized water and were dried using centrifuga-
tion at 1000 × g for 2 min. Fluorescent images were
detected on a GenePix 4000B scanner (Molecular Devices,
Sunnyvale, CA). Fluorescence intensity data were col-
lected using GenePix software (Molecular Devices) after
spot alignment. The dataset was submitted to the
National Center for Biotechnology Information's Gene
Expression Omnibus database [GEO:GSE11972]. Total
intensity values for each dye channel were stored as
comma-separated values data files and exported into
Microsoft Excel spreadsheets for subsequent analysis. The
fluorescence intensity data was background corrected and
analyzed using the limma software [67]. Specifically, the
"normexp" function advocated by Smyth [67] was used
for background subtraction followed by print-tip specific
loess normalization for dye intensity bias for each array.
The Cy5:Cy5 log2 ratios were further scale normalized
between arrays. A simple linear model fitting these ratios
as a function of an overall intercept(dye) and treatment
effects was fitted for each gene using the "eBayes" option
in limma. Statistical significance was based on the esti-
mated false discovery rates (FDR) as also provided by
limma.
Independent confirmation by relative real time RT-PCR
Transcript abundance of ORM1 was examined for liver
samples from Exp.1 (n = 4 fed Zn150 and n = 3 fed Zn2000).
Transcript abundances of 7 genes (ACY1, GLO1, PRDX4,
CPB2, ORM1, GSTM4 and HSP70.2) were evaluated for
23 liver samples from Exp. 2. The RNA sample for 1 pig
fed Zn150P (Exp.2) was of poor quality, and was not
included in the analyses. Glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) or 18S ribosomal RNA (18S) were used
as normalizing genes. Relative real time RT-PCR primers
(Table 3) were designed using Primer Express v. 2.0
(Applied Biosystems, Foster City, CA), and the assays were
performed on an ABI Prism 7000 Sequence Detection Sys-
tem (Applied Biosystems, Foster City, CA) in the Michigan
State University Center for Animal Functional Genomics.
First strand cDNA synthesis was performed with an oligo
(dT)14 primer using SuperScript II RNase H (Invitrogen
Life Technologies) following the manufacturer's protocol.
The cDNA was purified with QuickClean resin (Clontech)
followed by precipitation with sodium acetate and etha-
nol. Purified cDNAs were suspended in DNase/RNase-free
sterile water, and quantified using a spectrophotometer.
The cDNA samples were diluted to a final concentration
of 10 ng/μl and stored at -20°C until use. The real timeBMC Genomics 2008, 9:421 http://www.biomedcentral.com/1471-2164/9/421
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RT-PCR reactions included 50 ng of cDNA, 300 μM
primer and 1× SYBR Green Master Mix (Applied Biosys-
tems, Foster City, CA).
Relative quantification was determined using duplicate
cDNA samples from each animal. PCR amplification effi-
ciency plots were generated using serially diluted cDNA (4
dilutions) to confirm the use of GAPDH or 18S as normal-
izing genes for each primer pair. Results were recorded rel-
ative to a common liver cDNA sample from a pig fed Zn150
after normalizing for GAPDH or 18S. Relative gene expres-
sion changes were then computed using the 2-ΔΔCt method
[68].
Independent confirmation by northern blot hybridization
When PCR amplification plots did not reveal equal ampli-
fication efficiency for GAPDH with the target gene, confir-
mation of DDRT-PCR results for some genes was done by
northern blot analysis using the cDNA clones obtained by
DDRT-PCR, labeled as described previously [11] with an
18S rRNA for normalization.
Statistical analysis
The data were analyzed using analysis of variance based
on the MIXED procedure of SAS [69]. If the main effects
(Zn or phytase) or their interaction were not statistically
significant, the datasets were merged. For the relative real
time RT-PCR analyses, the model included pig nested
within the treatment interaction with the plate as random
effect. Satterthwaite's approximation was used to deter-
mine the error df for test [70]. A base 2 logarithmic trans-
formation (Log2) of the target and normalization gene Cts
was made to account for the exponential amplification of
cDNA prior to analyzing Ct values with the MIXED proce-
dure of SAS. The transformed target Cts, and GAPDH or
18S Cts modeled as covariates, were used in a regression-
based normalization of Cts in accordance with recom-
mendations by Poehlman [71]. These values were com-
pared to the results calculated by using the 2-ΔΔCt method
[68], and data is presented as fold changes. For northern
blot analyses, the blot by treatment interaction was used
in the model with pig as a random effect. The 18S rRNA
values were modeled as covariates for a regression-based
normalization of the genes' relative mRNA abundance.
Differences were considered to be significant when P <
0.05.
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Table 3: Real time RT-PCR primers used for DDRT-PCR and microarray confirmationa.
Gene Direction Primer sequence
CPB2 Forward 5'-TGG CAT GTC ATC AGA AAT GGT T-3'
CPB2 Reverse 5'-CTT GCT GGA ATC AGT AAA TTT CAC TCT-3'
GSTM4 Forward 5'-CCA TCC TGC GCT ACA TTG C-3'
GSTM4 Reverse 5'-CTC CAA AAC ATC CAC TCG AAT CT-3'
HSP70.2 Forward 5'-GTT CGG TTT CCG GCT TCA-3'
HSP70.2 Reverse 5'-CTC TCT CCG CAA ACA GCC TCT A-3'
ORM1 Forward 5'-TTG AGT GCA CGG GAA TCC A-3'
ORM1 Reverse 5'-CCA GCG GCC CAC ACA-3'
PRDX4 Forward 5'-ATG ACC TCC CTG TGG GTA GAT CT-3'
PRDX4 Reverse 5'-ACA GAC TTC TCC ATG TTT GTC AGT GT-3'
GAPDH Forward 5'-TGG AAA GGC CAT CAC CAT CT-3'
GAPDH Reverse 5'-CCA GCA TCG CCC CAT TT-3'
18Sb Forward 5'-CGG CTA CCA CAT CCA AGG AA-3'
18S Reverse 5'-GCT GGA ATT ACC GCG GCT-3'
aPrimers were designed using Primer Express v. 2.0 (1995–2000).
b18S primers were graciously provided by Dr. Susan Ewart of the Molecular Respiratory and Equine Genetics Laboratory at Michigan State 
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